Navigation Links
Chiltern Expands European Operations With a New Office in Belgium
Date:6/17/2009

LONDON, June 17 /PRNewswire/ -- Chiltern, a leading global clinical research organization, announced that it has opened a new office in Brussels and is pleased to have appointed Mr. Maurizio Passinisi as our new country manager for Belgium and The Netherlands.

Mr. Maurizio Passanisi received a Master of Science degree in Industrial Engineering from the Institut Superieur Industriel Liegeois of Liege (ISIL) in 1993 and a Master of Science degree in Management from Haute Ecole Commerciale (HEC) - University of Liege in 2008. Mr. Passanisi has over 15 years of experience working in both Pharmaceutical and Clinical Research areas.

"Belgium and The Netherlands have always been attractive locations to conduct clinical trials," Maurizio commented. "The quality of the research is outstanding. Belgium and The Netherlands have many key opinion leaders (KOL) involved in clinical research lending additional weight to the data and keeping these countries at the forefront of modern research."

"Chiltern is experiencing healthy growth despite the current economic climate," explained Lewis Cameron, Executive Vice President for Europe. "Chiltern is continuing its growth in Europe and will shortly announce further expansion in Eastern Europe. Our primary goal is to deliver expert, high quality services around the world and these actions demonstrate our commitment to regional expansion in order to serve our clients needs globally."

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1400 staff across 29 countries. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Further information is available at www.chiltern.com.

    For More Information Contact:

    Stuart McGuire                            Mac McElroy
    Chiltern International Ltd.               Chiltern International Inc.
    171 Bath Road                             1241 Volunteer Parkway
    Slough                                    Suite 950
    Berkshire SL1 4AA                         Bristol, TN 37620
    UNITED KINGDOM                            USA
    Tel:  +44 (0) 1753 512 000                Tel:  +1 (423) 968 9533
    Fax: +44 (0) 1753 511 116                 Fax: +1 (423) 968 3567
    Email: stuart.mcguire@chiltern.com        Email: mac.mcelroy@chiltern.com


'/>"/>
SOURCE Chiltern International Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Marco Romano, MD Joins Chiltern as Medical Director, Europe
2. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
3. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
4. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
5. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
6. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
7. Chiltern Wins Top Prize
8. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
9. Chiltern Opens a New Office in Russia
10. Chiltern Announces New Expansion in Portugal
11. Chiltern Expands Its Global Reach to Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
Breaking Medicine Technology: